SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-269018
Filing Date
2020-10-14
Accepted
2020-10-14 08:13:44
Documents
43
Period of Report
2020-10-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70190d8k.htm   iXBRL 8-K 33083
2 EX-99.1 d70190dex991.htm EX-99.1 31319
3 EX-99.2 d70190dex992.htm EX-99.2 33329
7 GRAPHIC g70190ex99_2s10g1.jpg GRAPHIC 251035
8 GRAPHIC g70190ex99_2s11g1.jpg GRAPHIC 335800
9 GRAPHIC g70190ex99_2s12g1.jpg GRAPHIC 177262
10 GRAPHIC g70190ex99_2s13g1.jpg GRAPHIC 207750
11 GRAPHIC g70190ex99_2s14g1.jpg GRAPHIC 298838
12 GRAPHIC g70190ex99_2s15g1.jpg GRAPHIC 258922
13 GRAPHIC g70190ex99_2s16g1.jpg GRAPHIC 221843
14 GRAPHIC g70190ex99_2s17g1.jpg GRAPHIC 307346
15 GRAPHIC g70190ex99_2s18g1.jpg GRAPHIC 306543
16 GRAPHIC g70190ex99_2s19g1.jpg GRAPHIC 270801
17 GRAPHIC g70190ex99_2s1g1.jpg GRAPHIC 422012
18 GRAPHIC g70190ex99_2s20g1.jpg GRAPHIC 435748
19 GRAPHIC g70190ex99_2s21g1.jpg GRAPHIC 479065
20 GRAPHIC g70190ex99_2s22g1.jpg GRAPHIC 73465
21 GRAPHIC g70190ex99_2s23g1.jpg GRAPHIC 49342
22 GRAPHIC g70190ex99_2s24g1.jpg GRAPHIC 262229
23 GRAPHIC g70190ex99_2s25g1.jpg GRAPHIC 307425
24 GRAPHIC g70190ex99_2s26g1.jpg GRAPHIC 332405
25 GRAPHIC g70190ex99_2s27g1.jpg GRAPHIC 278297
26 GRAPHIC g70190ex99_2s28g1.jpg GRAPHIC 61524
27 GRAPHIC g70190ex99_2s2g1.jpg GRAPHIC 913095
28 GRAPHIC g70190ex99_2s3g1.jpg GRAPHIC 260262
29 GRAPHIC g70190ex99_2s4g1.jpg GRAPHIC 379748
30 GRAPHIC g70190ex99_2s5g1.jpg GRAPHIC 385668
31 GRAPHIC g70190ex99_2s6g1.jpg GRAPHIC 116339
32 GRAPHIC g70190ex99_2s7g1.jpg GRAPHIC 508719
33 GRAPHIC g70190ex99_2s8g1.jpg GRAPHIC 438993
34 GRAPHIC g70190ex99_2s9g1.jpg GRAPHIC 276119
35 GRAPHIC g70190g1014052618705.jpg GRAPHIC 2419
  Complete submission text file 0001193125-20-269018.txt   12116392

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rvnc-20201014.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvnc-20201014_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvnc-20201014_pre.xml EX-101.PRE 10951
36 EXTRACTED XBRL INSTANCE DOCUMENT d70190d8k_htm.xml XML 3238
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 201238255
SIC: 2834 Pharmaceutical Preparations